JASIYA PAIKA: Open Payments
NPI 1164977492 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,299 in 100 payments from 37 companies in 2025. Trend: 2023 $2,523 · 2024 $2,581 · 2025 $2,299
Food & beverage: $2,299
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $331 |
| Janssen Biotech, Inc. | 11 | $223 |
| Daiichi Sankyo Inc. | 6 | $166 |
| Incyte Corporation | 5 | $133 |
| PFIZER INC. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
| ABBVIE INC. | 4 | $93 |
| Celgene Corporation | 5 | $81 |
| Merck Sharp & Dohme LLC | 4 | $79 |
Products named: ERLEADA, MONJUVI, LIBTAYO, LYNPARZA, DATROWAY, KEYTRUDA, ENHERTU, EPKINLY.
Industry payments across AZ — which companies pay providers there.
